Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Oncology Market Trends: Predictive Biomarkers, New IO Targets And Tougher Competition

Mar 09 2022

• By Mark Ratner

Cancer cells on scientific background.3d illustration

Related Content

Accelerated Approval Makes Big Splash In 2021 Novel Agents, Despite Crackdown On ‘Dangling’ Cancer Claims

Jan 19 2022

Broader Horizons For Advanced Biotech In 2022: New Targets, Settings For IO, Cell And Gene Therapy

Feb 01 2022

Related Companies

Roche Holding AG

Genentech, Inc.

Gilead Sciences, Inc.

Immunomedics, Inc.

Eli Lilly and Company

Additional Topics

ImmunoOncology Clinical Trials Market Intelligence Strategy Research & Development Regenerative Medicine Approvals Gene Therapy Financing Cancer

More from Market Intelligence

More from In Vivo

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window